Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Shigella sonnei vaccine - GSK

Next Previous
X
Search
Drug Profile

Shigella sonnei vaccine - GSK

Alternative Names: 1790GAHB vaccine; GSK-3536852; GSK-3536852A; GSK-3902986A; GVGH Shigella sonnei 1790GAHB vaccine

Latest Information Update: 28 Apr 2023

Price :

$50 *

Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Novartis
  • Developer GSK
  • Class Bacterial vaccines; Conjugate vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Phase II Shigella infections

Most Recent Events

  • 28 Apr 2023 Shigella sonnei vaccine is still in phase II trials for Shigella infections (Prevention) in USA (IM) (GSK pipeline, April 2023)
  • 10 Nov 2022 Phase I development for Shigella infections (Prevention) is ongoing United Kingdom (GlaxoSmithKline pipeline, November 2022)
  • 29 Apr 2020 Discontinued - Phase-I for Shigella infections (Prevention) in United Kingdom (Intradermal) (GlaxoSmithKline pipeline, April 2020)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top